Researchers commonly use serum or plasma zinc and proxy indicators to assess zinc status, but each has limitations. Longitudinal zinc supplementation affected exchangeable zinc pool (EZP) size and reflected the expected difference in bioavailability for two forms of supplementation. Researchers did not find an effect of inflammation on EZP size, which may support its use as a biomarker for comparisons between different interventions.